Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.37% |
| 2 | Healthcare | 7.45% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.1% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HA
2576
DELISTED
Hawaiian Holdings, Inc.
HA
| $5.31M | ﹤0.01% |
493,101
-143,924
| -23% | -$1.25M |
|
2577
Materion
MTRN
$4.33B
| $5.3M | ﹤0.01% |
46,441
-10,789
| -19% | -$1.17M |
|
2578
iShares Core MSCI EAFE ETF
IEFA
$192B
| $5.27M | ﹤0.01% |
78,030
-37,171
| -32% | -$2.52M |
|
2579
Excelerate Energy
EE
$1.22B
| $5.26M | ﹤0.01% |
258,670
-24,181
| -9% | -$505K |
|
2580
Sumitomo Mitsui Financial
SMFG
$164B
| $5.26M | ﹤0.01% |
611,130
+274,518
| +82% | +$2.27M |
|
2581
A10 Networks
ATEN
$2.16B
| $5.25M | ﹤0.01% |
360,091
-227,349
| -39% | -$3.29M |
|
2582
Forestar Group
FOR
$1.47B
| $5.25M | ﹤0.01% |
+232,875
| New | +$4.48M |
|
|
NVEI
2583
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $5.24M | ﹤0.01% |
177,206
-449,382
| -72% | -$15.8M |
|
2584
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.65B
| $5.24M | ﹤0.01% |
78,800
+1,100
| +1% | +$73.5K |
|
2585
Invesco Senior Loan ETF
BKLN
$6.97B
| $5.23M | ﹤0.01% |
248,798
-129,206
| -34% | -$2.69M |
|
2586
Integra LifeSciences
IART
$1.33B
| $5.23M | ﹤0.01% |
127,141
+74,785
| +143% | +$3.6M |
|
2587
LXP Industrial Trust
LXP
$3.52B
| $5.22M | ﹤0.01% |
107,005
+82,714
| +341% | +$4.09M |
|
2588
CALL
BridgeBio Pharma
BBIO
$16.1B
| $5.21M | ﹤0.01% |
302,700
+199,900
| +194% | +$3.01M |
|
2589
Health Catalyst
HCAT
$154M
| $5.21M | ﹤0.01% |
416,499
-1,178,776
| -74% | -$14M |
|
2590
Manulife Financial
MFC
$74B
| $5.2M | ﹤0.01% |
275,161
-50,127
| -15% | -$957K |
|
2591
CALL
Dentsply Sirona
XRAY
$2.75B
| $5.2M | ﹤0.01% |
130,000
+70,000
| +117% | +$2.78M |
|
2592
PUT
TripAdvisor
TRIP
$1.65B
| $5.19M | ﹤0.01% |
315,000
-500
| -0.2% | -$8.46K |
|
2593
iShares S&P 500 Value ETF
IVE
$49.1B
| $5.19M | ﹤0.01% |
32,211
+16,385
| +104% | +$2.52M |
|
|
ZING
2594
DELISTED
FTAC Zeus Acquisition Corp. Class A Common Stock
ZING
| $5.19M | ﹤0.01% |
498,030
-9,382
| -2% | -$97K |
|
2595
Assured Guaranty
AGO
$3.73B
| $5.19M | ﹤0.01% |
93,003
+61,767
| +198% | +$3.28M |
|
2596
Starbucks
SBUX
$121B
| $5.19M | ﹤0.01% |
52,382
-1,184,294
| -96% | -$123M |
|
2597
Nu Skin
NUS
$254M
| $5.18M | ﹤0.01% |
155,977
+137,278
| +734% | +$5.05M |
|
2598
Vanguard Total Bond Market
BND
$158B
| $5.17M | ﹤0.01% |
71,163
+44,607
| +168% | +$3.27M |
|
2599
CorVel
CRVL
$3.03B
| $5.16M | ﹤0.01% |
80,070
+17,358
| +28% | +$1.16M |
|
2600
Li Auto
LI
$14B
| $5.14M | ﹤0.01% |
146,330
-465,719
| -76% | -$13.1M |
|
Similar funds
Millennium Management's Q2 2023 Portfolio in Review
As of Q2 2023, Millennium Management held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Millennium Management deployed $14B of net new capital in Q2 2023, opening 869 new positions and adding to 2,214 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Millennium Management's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Millennium Management's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Millennium Management fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Millennium Management's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Millennium Management opened 869 new positions and closed 1,192 in Q2 2023.
- Millennium Management's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.